跳至主要内容
临床试验/NCT00202826
NCT00202826已完成3 期

Parapneumonic Effusion in Children Study

Corewell Health West2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2003年11月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
30
试验地点
2
主要终点
establish morbidity outcomes

研究概览

简要总结

The purpose of this study is to determine the best treatment for children with a fluid collection in the chest associated with an underlying pneumonia. Researchers generally agree that a child with a large fluid collection in the chest need to have the fluid drained in addition to anitbiotics. There have been many treatments studied in children that have been shown to be effective and safe, but the treatments have never been compared to each other in a randomized controlled study.

The optimal treatment of pediatric parapneumonic effusions remains controversial. The objective of this study is to compare the use of conventional management (antibiotics with thoracostomy tube placement) with primary thorascopic drainage (see protocol). Our hypothesis is that pediatric patients with parapneumonic effusion, regardless of pleural fluid composition and loculations, have decreased morbidity when treated with early thoroscopic adhesiolysis (VATS) compared with conservative treatment.

详细描述

The ultimate objective of this study is to rationalize treatment decisions. It is our hope that this pilot study will provide the basis for further randomized prospective studies. The expected benefit is that the current treatment and outcome of pediatric parapneumonic effusions will be determined. Insights into the therapy that results in the least morbidity, hospital days, (and therefore cost) will be elucidated. If our hypothesis is valid, then a more aggressive surgical approach to the treatment of a parapneumonic effusion may be warranted. If the hypothesis is not valid, then the appropriate treatment for a parapneumonic effusion, irrespective of institution and personal opinion, should become more apparent.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
0 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • consecutive pediatric patients with a bacterial pneumonia and parapneumonic effusion
  • community acquired disease
  • children age 0 to 18 years

排除标准

  • hospital acquired pneumonia
  • thoracentesis or chest tube drainage outside hospital
  • patients with incorrected cardiac disease

结局指标

主要结局

establish morbidity outcomes

number of procedures

days with a chest drainage device

duration of fever

total hospital days

次要结局

  • Days of oxygen requirement
  • Days of narcotic use
  • Complication rate
  • Number of radiographic procedures

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验